Tuesday, May 20, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

‘All New Vaccines’ in the U.S. to Undergo Placebo-Controlled Safety Testing

by Barbara Loe Fisher and Amber Baker
placebo shots
On Apr. 30, 2025, the U.S. Department of Health and Human Services (DHHS) announced that all newly developed vaccines will now be ...

HHS Halts Funding for Development of Next-Generation COVID Biologics

by Amber Baker
HHS Halts Funding for Development of Next-Generation COVID Biologics
The U.S. Department of Health and Human Services (DHHS) has stopped U.S. government funding for the development of next-generation COVID-19 ...

Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.

by Natasha Hobley
Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.
Patients in England with advanced skin melanoma are receiving a “revolutionary” new therapeutic cancer vaccine in a National Health Service ...

Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants

by TVR Staff
1,100+ Rn Degree Stock Photos, Pictures & Royalty-Free Images - iStock
On Dec. 5, 2024, formulation technology company VitriVax, Inc. of Boulder, Colorado was awarded a two-year, $3.6 million grant by ...

WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development

by Amber Baker
WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development
A new World Health Organization (WHO) study published in eBioMedicine last week highlights 17 viral and bacterial pathogens that are ...

Moderna/Merck’s Combo Melanoma Cancer mRNA Therapeutic May Be Ready Next Year

by TVR Staff
Moderna/Merck’s Combo Melanoma Cancer mRNA Therapeutic May Be Ready Next Year
The CEO of Moderna, Inc., Stephane Bancel, said last week that his company may introduce a new mRNA (messenger ribonucleic ...

U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic

by Amber Baker
U.S. Government Gives Moderna 6 Million to Develop mRNA Bird Flu Biologic
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an ...

BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine

by TVR Staff
BARDA Awards .27 Million Contract to Evaluate Oral Pill COVID Vaccine
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical ...

Only Remaining HIV Vaccine Efficacy Trial Fails in Africa

by TVR Staff
Only Remaining HIV Vaccine Efficacy Trial Fails in Africa
The latest effort to develop an HIV (human immunodeficiency viruses) vaccine in Uganda, Tanzania and South Africa was halted on ...

In this section

Search in Archive

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.